REGEMED MEDICAL SOLUTIONS
REGEMED is building a scalable platform to standardize autologous regenerative treatments, starting in aesthetic medicine and expanding into broader clinical applications.
● Class IIa medical devices
● Science-based regenerative medicine
● First indication: aesthetic medicine
● Scalable model with recurring consumables
The Problem
A Global Burden of Skin Aging and Tissue Damage
Skin aging and tissue damage affect the entire population, encompassing not only aesthetic deterioration but also chronic wounds, ulcers, and impaired skin repair mechanisms.
Market context & Trend
Aesthetic and regenerative skin treatments continue to grow year after year, driven by the increasing prevalence of skin aging, chronic wounds, and demand for effective tissue repair solutions.
Limitations of current solutions
Current solutions are often invasive, provide mainly superficial effects, and rely on manual, non-standardized procedures with high operator-dependent variability.
The Regemed Solution
REGEMED develops an automated medical device that processes the patient’s own tissue to generate, within minutes, a personalized, safe, and standardized regenerative treatment.
Technology & Competitive Advantage
01
Combines personalization with standardization
02
Autologous technology (maximum safety)
03
Platform extensible to multiple indications
Vision & Roadmap
From Aesthetic Medicine to Regenerative Medicine
Go-to-Market Strategy
Strategic entry into aesthetic medicine
Application Scale-Up
Progressive expansion into new medical applications
Platform Value Creation
Building a leading platform for autologous regenerative treatments
Programs, Awards & Recognitions
